|
|
èPrescription
Drug Information for Consumers & Professionals

Jiaogulan
Scientific Name(s): Gynostemma pentaphyllum (Thunb.) Makino.
Family: Cucurbitaceae (Squashes)
Common Name(s): Jiaogulan , Penta tea , Amachazuru (Japan) ,
Southern ginseng , Dungkulcha (Korea)
Clinical Overview
Uses of Jiaogulan
Studies on Gynostemma have found that the plant is effective
in regulating blood pressure, strengthening the immune
system, lowering cholesterol, and in increasing stamina and
endurance properties. Gynostemma has also been found to have
hyperlipidemic, lipid peroxidation, adaptogenic, anticancer,
cardio- and cerebrovascular effects.
Jiaogulan Dosing
The adaptogenic use of jiaogulan is standardized on an
extract containing 85% gypenosides, with a daily dose of 60
to 180 mg gypenosides recommended; however, published
studies to justify this dose are lacking.
Contraindications
Contraindications have not yet been identified.
Pregnancy/Lactation
Information regarding safety and efficacy in pregnancy and
lactation is lacking.
Jiaogulan Interactions
None well documented.
Jiaogulan Adverse Reactions
The side effects of Gynostemma include severe nausea and
increased bowel movements.
Toxicology
No data available for human toxicity.
Botany
Gynostemma pentaphyllum is a climbing, perennial vine native
to China, Japan, and parts of southeast Asia. The plant is
dioecious, that is, it carries male and female flowers on
separate plants. While the plant grows abundantly and is
harvested from the wild, it has been brought under
cultivation and tissue culture has been achieved. 1 , 2 , 3
, 4 Adulteration by Cayratia japonica has been noted.
3
History
Jiaogulan has been incorporated into traditional Chinese
medicine only in the last 20 years. The plant has a history
of folk use in the Guizhou province in China. Its properties
are said to have been investigated when a Chinese census
revealed a large number of elderly people in the province
reported using the plant. Investigation as a potential
sweetening agent stimulated chemical investigations in
Japan. Commercialization and scientific study of the leaves
have been promoted by provincial Chinese authorities, and
the discovery that several ginseng saponins occur in the
leaves has prompted aggressive promotion of the product as a
substitute for ginseng. The appearance of jiaogulan in
American commerce has been heralded by publication of a
popular book. 5
Chemistry
A large series of dammarane triterpene saponins, gypenosides
1-82, have been isolated from the leaves, principally by
Takemoto's group. 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14
Several of these saponins are identical to those found in
ginseng. Specifically, gypenoside 3 is identical to
ginsenoside Rb1, gypenoside 4 is identical to ginsenoside
Rb3, gypenoside 8 is identical to ginsenoside Rd, and
gypenoside 12 is identical to ginsenoside F2. Many of the
other gypenosides are closely related structurally to the
ginsenosides and include the 6′-malonyl derivatives
characteristic of ginseng. 15 The content of saponins is
comparable to that of ginseng roots. However, wide variation
in the amount and nature of gypenosides has made production
of a product standardized with specific gypenosides somewhat
problematic. Most current products are standardized on total
saponin content. The reasons for this variation have been
investigated but have not been fully elucidated.
Other constituents reported from Gynostemma pentaphyllum
include sterols with the ergostane, cholestane, and
stigmastane skeletons, 16 , 17 , 18 , 19 , 20 with several
examples containing an acetylenic functionality, which is
considered unusual in plants. 21 The flavonoid glycosides
rutin, ombuoside, 22 and yixingensin 23 , 24 have also been
identified.
The related species G. compressum Chen and Liang have
yielded dammarane saponins related to the gypenosides.
25
Jiaogulan Uses and Pharmacology
Though the plant contains ginseng and ginseng-like saponins,
it has not been reported to contain the other types of
biologically active compounds, acetylenes, and
polysaccharides found in ginseng. Thus, while ginseng
pharmacology presents a reasonable starting point for
investigation, jiaogulan cannot be considered as
pharmacologically identical to ginseng.
Hyperlipidemia
Animal data
Oral administration of a gynostemma decoction in combination
with Nelumbo nucifera and Crataegus cuneata was found to
lower triglycerides and cholesterol in rats and quail.
However, a dose response was not demonstrated. 26
Administration of an aqueous extract of the whole plant to
rats in chow over 12 weeks resulted in a reduction in serum
levels of total cholesterol and beta-lipoproteins. 27 A
second study in mice and rats given 200 mg/kg PO of the
crude saponin demonstrated lower total cholesterol (TC) and
VLDL but increased HDL/LDL. 28
Clinical data
A clinical study of hyperlipoproteinemic subjects also found
a decrease in TC with increased HDL/TC at a dose of 10 mg
given 3 times daily for 30 days. 29 A study of 105 patients
confirmed these effects. 30
Lipid peroxidation
Animal data
An antioxidant effect of gypenosides was reported in
phagocyte, endothelial cell, and liver microsome systems. 31
Further study by the same group 32 explored these effects in
vascular endothelial cells injured by hydrogen peroxide. Rat
microsome studies also have found similar effects for crude
gypenosides. 33
Clinical data
Research reveals no clinical data regarding the use of
jiaogulan for lipid peroxidation.
Adaptogenic
Despite the wide reputation of ginseng as an adaptogen, few
studies of jiaogulan have been published on the topic.
Animal data
Chen 34 found an increased tolerance to fatigue in forced
swimming and hanging models in mice, and enhanced tolerance
to anoxia, along with potentiation of pentobarbital
hypnosis.
Clinical data
Research reveals no clinical data regarding the use of
jiaogulan as an adaptogen.
Cardio- and cerebrovascular effects
Animal data
The hot water extract of Gynostemma pentaphyllum was found
to activate platelet aggregation. However, the active
principle was not elucidated. 35 Gypenosides inhibited
platelet aggregation in another study. 36 In rabbits, crude
gypenosides decreased heart rate, increased stroke volume,
dilated blood vessels, and reduced blood pressure while
slightly increasing cardiac output. 37 Purified gypenosides
5 and 10 were found to lower systolic and diastolic blood
pressure, decrease coronary, brain, and peripheral blood
vessel resistance, raise coronary flow, and lower heart rate
in dogs. 38 Crude gypenosides protected against cerebral
ischemic damage in a rabbit model. 39
Clinical data
Research reveals no clinical data regarding the use of
jiaogulan for cardio- and cerebrovascular effects.
Cancer and immunologic effects
Animal data
An extract of Gynostemma inhibited the growth of a rectal
adenocarcinoma cell line, 40 while total gypenosides
inhibited growth of A549, Calu 1, and 592/9 carcinoma cells
more potently (1 to 10 mg/L) than Hela and Colo 205 cells.
41 Both callus and field grown Gynostemma increased the
lifespan of mice bearing Ehrlich's ascites carcinoma, an
effect attributed to immune enhancement. 42 Crude
gypenosides also had activity versus S-180 cells both in
vitro and in vivo. 43 Gypenosides protected against
cyclophosphamide-induced bone marrow and spermatozoal
mutagenesis when given orally at 40 to 160 mg/kg to mice. 44
Similar treatments enhanced immune function in another
report. 45
Clinical data
Cancer patients given jiaogulan granules after chemotherapy
showed improved immune function by several endpoints.
46
Other
Experimental senility in mice induced by D-galactose was
attenuated by intraperitoneal (IP) injection of Gynostemma
aqueous extract. 47
Dosage
The adaptogenic use of jiaogulan is standardized on an
extract containing 85% gypenosides, with a daily dose of 60
to 180 mg gypenosides recommended; however, published
studies to justify this dose are lacking.
Pregnancy/Lactation
Information regarding safety and efficacy in pregnancy and
lactation is lacking.
Interactions
None well documented.
Adverse Reactions
Side effects reported in clinical studies included severe
nausea and increased bowel movements. 48
Toxicology
The LD50 in mice for the aqueous extract has been reported
as 2.8 g/kg IP. However, LD50 for the oral route could not
be determined. 34 Another study found an oral LD50 of 49 g/kg
for the crude extract with no organ toxicity at 4 g/kg daily
for 90 days. 49 A third study of two different extracts
found an LD50 of 1 to 2 g/kg IP in mice. 50 A rat LD50 of
1.9 g/kg IP has also been reported. 34
Bibliography
1. Zhang ZH, et al. Propagation of Gynostemma pentaphyllum
by tissue culture. China J Chinese Materia Medica . 1989;
14(6):335–36.
2. Liu X, et al. Tissue culture and plantlet regeneration of
Gynostemma pentaphyllum . Journal of Chinese Medicinal
Materials . 1989; 12(6):8–10.
3. Wu M, et al. Pharmacognosy of Gynostemma pentaphyllum and
Cayratia japonica . Zhongyaocai . 1987; (4):22–25.
4. Ding S, et al. Pharmacognostical study of Gynostemma (Cucurbitaceae)
in China. Chinese Pharmaceutical Journal . 1994;
29(2):79–83.
5. Blumert M, et al. Jiaogulan ( Gynostemma pentaphyllum )
China's immortality herb. Badger, CA: Torchlight Publishing,
1999.
6. Nagai M, et al. Two glycosides of a novel dammarane
alcohol from Gynostemma pentaphyllum . Chem Pharm Bull .
1981; 29(3):779–83.
7. Takemoto T, et al. Studies on the constituents of
Gynostemma pentaphyllum Makino. I. Structures of
gypenosides. I-XIV. Yakugaku Zasshi . 1983; 103:173.
8. Takemoto T, et al. Studies on the constituents of
Gynostemma pentaphyllum Makino. II. Structures of
gypenosides. XV-XXI. Yakugaku Zasshi . 1983;
103(10):1015–23.
9. Takemoto T, et al. Studies on the constituents of
Cucurbitaceae plants. XI. On the saponin constituents of
Gynostemma pentaphyllum Makino. Yakugaku Zasshi . 1984;
104(10):1043–49.
10. Takemoto T, et al. Studies on the constituents of
Cucurbitaceae plants. XII. On the saponin constituents of
Gynostemma pentaphyllum Makino. Yakugaku Zasshi . 1984;
104(11):1155–62.
11. Takemoto T, et al. Studies on the constituents of
Cucurbitaceae plants. XIV. On the saponin constituents of
Gynostemma pentaphyllum Makino. Yakugaku Zasshi . 1986;
106(8):664–70.
12. Yoshikawa K, et al. Studies on the constituents of
Cucurbitaceae plants. XV. On the saponin constituents of
Gynostemma pentaphyllum Makino. Yakugaku Zasshi . 1986;
106(9):758–63.
13. Yoshikawa K, et al. Studies on the constituents of
Cucurbitaceae plants. XVI. On the saponin constituents of
Gynostemma pentaphyllum Makino. Yakugaku Zasshi . 1987;
107(4):262–67.
14. Yoshikawa K, et al. Studies on the constituents of
Cucurbitaceae plants. XVII. On the saponin constituents of
Gynostemma pentaphyllum Makino. Yakugaku Zasshi . 1987;
107(5):361.
15. Kuwahara M, et al. Dammarane saponins of Gynostemma
pentaphyllum Makino and the isolation of malonylginsenosides-Rb1,
Rd, and malonylgypenoside V. Chem Pharm Bull . 1989;
37(1):135–39.
16. Akihisa T, et al. 14α-methyl-5α-ergosta-9(11),24(28)-dien-3β-ol,
a sterol from Gynostemma pentaphyllum . Phytochemistry .
1987; 26(8):2412–13.
17. Akihisa T, et al. 24,24–Dimethyl-5α-cholestan-3β-ol,
a sterol from Gynostemma pentaphyllum . Phytochemistry .
1988; 27(9):2931–33.
18. Akihisa T, et al. 24,24–Dimethyl-5α-cholest-8–en–3β-ol,
a new sterol from Gynostemma pentaphyllum . Yukagaku . 1988;
37(8):659–62.
19. Akihisa T, et al. (24R)-and (24S)-14α-methyl-5α-ergost-9(11)-en
3β-ols from Gynostemma pentaphyllum . Phytochemistry .
1989;28(4):1271–73.
20. Akihisa T, et al. 4α, 14α-dimethyl-5α-ergosta-7,9(11),24(28)trien-3β-ol
from Phaseolus vulgaris and Gynostemma pentaphyllum .
Phytochemistry . 1990; 29(5):1647–51.
21. Akihisa T, et al. Isolation of acetylenic sterols from a
higher plant. Further evidence that marine sterols are not
unique. J Org Chem . 1989; 54:606–10.
22. Hu L, et al. Dammarance-type glycosides from Gynostemma
pentaphyllum . Phytochemistry . 1997; 44(4):667.
23. Fang Z, et al. Isolation and identification of
flavonoids glycosides and organic acids from Gynostemma
pentaphyllum . China J of Chinese Materia Medica . 1989;
14(11):676–78.
24. Si J, et al. Isolation and identification of flavonoids
from Gynostemma yixingense . Zhiwu Xuebao . 1994; 36(3):239.
25. Ding S, et al. Gycomoside I: a new dammarane saponin
from Gynostemma compressum . Planta Med . 1993; 373.
26. La Cour B, et al. Traditional Chinese medicine in
treatment of hyperlipidaemia. J Ethnopharmacol . 1995;
46:125–29.
27. Geng W, et al. Effects of Gynostemma pentaphyllum
extract on T-lymphocyte and lipid metabolism in rats.
Guangxi Med J . 1988; 10(1):8–9.
28. Dai H, et al. Effects of the total saponin of Gynostemma
pentaphyllum on lipoproteins. Chinese Tradit Herbal Drugs .
1989; 20(4):172–73.
29. Hu X, et al. Antilipemic effect Gynostemma pentaphyllum
in patients. Fujian Medical Journal . 1988; 10(5):4–6.
30. Zhou H, et al. Treatment of hyperlipidemia with
Gynostemma pentaphyllum Jiaogulan. Hunan Med J . 1991;
8(5):259–60.
31. Li L, et al. Protective effect of gypenosides against
oxidative stress in phagocytes, vascular endothelial cells,
and liver microsomes. Cancer Biother . 1993; 8(3):263–272.
32. Li L, et al. Protection of vascular endothelial cells
from hydrogen peroxide-induced oxidant injury by gypenosides
saponins of Gynostemma pentaphyllum . Phytother Res 1993;
7(4):299–304.
33. Li L, et al. Protective effects of gypenosides on rat
hepatic lipid peroxidation and membrane fluidity damage: in
vitro studies. Chinese Pharm Bull . 1991; 7(5):341–44.
34. Chen J, et al. Antistress action of Gynostemma
pentaphyllum . Chinese Tradit Patent Med . 1989;
11(1):31–32.
35. Takagi J, et al. A new platelet aggregation factor from
Gynostemma pentaphyllum Makino. Chem Pharm Bull . 1985;
33(12):5568–71.
36. Wu J, et al. Effects of gypenosides on platelet
aggregation, release, and cAMP level in rabbits. Chinese J
Pharmacol Toxicol . 1990; 4(1):54–57.
37. Li Y, et al. Effects of total gypenosides on heart
function and blood pressure of rabbits. Acta Academiae
Medicinae Shandong . 1990; 28(3):34–36.
38. Chen L, et al. Comparison between the effects of
gypenosides and ginsenosides on cardiac function and
hemodynamics in dogs. Chinese J Pharmacol Toxicol . 1990;
4(1):17–20.
39. Wang Z, et al. Protective effect of gypenoside on acute
incomplete cerebral ischemia in rabbits. Chinese J Pharmacol
Toxicol . 1992; 6(3):204–06.
40. Jin M, et al. Effects of extract of Gynostemma
pentaphyllum on human rectal adenocarcinoma cell. Modern
Applied Pharmacy . 1992; 9(2):49–52.
41. Liu H, et al. Suppression effects of gypenosides on
cultured human carcinoma cells. Journal of Xi'an Medical
University . 1994; 15(4):346–48.
42. Wang Z, et al. Inhibitory effect of Gynostemma
pentaphyllum on Ehrlich's ascites carcinoma. Tumor . 1990;
10(6):246–49.
43. Wang Y, et al. Antineoplastic action of gypenosides.
Chinese J Integrated Tradit Western Med . 1988; 8(5):286.
44. Wang Y, et al. Effects of gypenosides on mutagenesis
induced by cyclophosphamide in mice. Chinese Pharmacol Bull
. 1994; 10(6):457–59.
45. Tong K, et al. Immunological effects of Gynostemma
pentaphyllum in mice. Jiangsu Journal of Traditional Chinese
Medicine . 1989; (4):184–86.
46. Wang J, et al. Immunological effects of jiaogulan
granule in 19 cancer patients. Zhejiang Journal of
Traditional Chinese Medicine . 1989; 24(10):449.
47. Xu F, et al. Anti-aging actions of Gynostemma
pentaphyllum and its compound formula. Chinese Tradit Patent
Med . 1989; 11(5):29–30.
48. Chen Z, et al. Progress in the research on the
pharmacology of Gynostemma pentaphyllum . Journal of Chinese
Medicinal Materials . 1989; 12(6):42–44.
49. Li R, et al. Chemical and pharmacological studies on
Gynostemma pentaphyllum . Journal of New Chinese Medicine .
1988; 20(4):51–53.
50. Liu X, et al. Pharmacological studies on the total
saponin of Gynostemma pentaphyllum from Guangxi. Chinese
Tradit Patent Med . 1989; 11(8):27–29.
THANK YOU DRUG.COM FOR ALL INFORMATION
MORE INFORMATION PLEASE VISIT
JIAOGULAN
( GYNOSTEMMA PENTAPHYLLUM ) Herbal Jiaogulan
Jiaogulan4u Promoting Health Through Organic Agriculture of
Jiaogulan as a Leading Sustainable Organization as well as a
proud supporter of organic farmers on the hill of North Of
ChiangMai.
We're not your typical produce supplier. Our
Herbal Jiaogulan freshest and most care, organic
produce on the market.
We are committed to operating our Jiaogulan business in ways
that are increasingly sustainable, supporting environmental
health and the well being of people involved in all aspects
of our business and communities.
Take a look around all web site of Jiaogulan
Present and learn more about those company and why
more Herbal Jiaogulan retailers and other resellers are
choosing to buy their produce from Organically Grown.
We have collected Jiaogulan Plant From
the mountain, also we use no chemical for our Jiaogulan
Products.
The area is Over 6000 Feet above the means sea level
Northern Thailand. The weather on the mountain of ChiangMai
is perfect to growing the best quality of Jiaogulan. We pick
our gourmet tea when the growth is right and tender and
local wisdom make our Jiaogulan not the same quality of
other. ( Not Young Jiaogulan )
|
Jiaogulan
4u' s product is the richest and not sweet like other
kind of Jiaogulan |
 |
 |
 |

|
|
Jiaogulan
in Capsules
|
Jiaogulan
Tea |
Jiaogulan
Tea Bag |
Jiaogulan
tea |
Product is the richest and not sweeter like other kind of Jiaogulan
Contact Jiaogulan4u
Herb - ChiangMai Northern Thailand
99 / 62 M 12 Sunnameng Sun Sai ChiangMai Thailand 50210
Tel & Fax 66 53398767, 66 85 0330238
chiangmai@thai4u-thailand.com
guide2544@yahoo.com
|